Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2008

View Archived Issues

Studies show analgesic efficacy of ARRY-797 in postsurgical dental pain

Pooled GOUT 1 and GOUT 2 data detail effects of pegloticase

Recent University of Aberdeen patent discloses novel agents for bone disorders

New therapeutic agents for neurological disorders reported in recent patent literature

Thalidomide not effective in treating amyotrophic lateral sclerosis

Antimicrobial activity of host defense peptide mimetics described

NIH awards SBIR grant to BioSante to develop pulmonary delivery of IFN-alpha

Boehringer Ingelheim commences phase III pivitol program for Vargatef

DSMC authorizes Bioniche to continue phase III Urocadin trial in bladder cancer

Innocoll receives FDA fast track designation for Gentamicin Surgical Implant

Relistor approved in Australia for opioid-induced constipation

Life Science Pharmaceuticals enters into agreement with Abbott for Antibody 806

Eli Lilly and United Therapeutics enter license and supply agreement for PAH

SciClone reaches agreement with FDA on SPA for phase III thymalfasin trial

Solvay discontinues R&D activities of antiobesity compound SLV-319

Theratechnologies completes treatment of patients in extension phase of tesamorelin trial

Biotie acquires Elbion NV's subsidiary Elbion GmbH

Proteome Systems changes name to Tyrian Diagnostics

Affymax completes enrollment in EMERALD 2 phase III clinical trial of Hematide

Serenity initiates phase II clinical study of intranasal drug for urology indication

Novel dopamine D3 receptor agonists and antagonists described by Pfizer

Preclinical activity of PF-03800130 shows benefit in bipolar disorder-associated mood symptoms

Phase II results with rivaroxaban in acute coronary syndromes reported

New compounds for hypogonadism described in recent GSK patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...